Buradasınız

Anasayfa » Content

Sekonder Hipertansiyon Nedeni Olarak Primer Hiperparatiroidi

Primary Hyperparathyroidism as a Cause of Secondary Hypertension

Journal Name:

  • Türk Nefroloji, Diyaliz ve Transplantasyon Dergisi

Publication Year:

  • 2012
DOI: 
DOI 10.5262/tndt.2012.1003.16

Key Words:

Keywords (Original Language):

Author NameFaculty of Author
Abstract (2. Language): 
Primary hyperparathyroidism is an endocrinological disorder characterized by secretion of parathormone and hypercalcemia. More than 80% of the cases are asymptomatic and are diagnosed during differential diagnosis of hypercalcemia. Fatigue, malaise, persistent nephro-urolithiasis, polydipsia and polyuria are the most common fi ndings in symptomatic patents. We present a patient with secondary hypertension due to primary hyperparathyroidism.
Bookmark/Search this post with
Abstract (Original Language): 
Primer hiperparatiroidizm (PHPT), paratiroid bezinin fazla miktarda parathormon (PTH) salgılaması sonucu hiperkalsemi ile karakterize endokrin bozukluktur. Hastaların %80’inden fazlası asemptomatik olup sıklıkla tesadüfen yüksek serum kalsiyum değerleri saptanması sonucu tanı alırlar. Semptomatik hastaların çoğunda halsizlik, bitkinlik ve kolay yorulma, tekrarlayan taş düşürme öyküsü, poliüri ve polidipsi gibi şikâyetler bulunur. Biz sekonder hipertansiyon nedeni araştırılan bir hastada primer hiperparatiroidinin sebep olarak saptandığı bir olgu sunuyoruz
FULL TEXT (PDF): 
PDF icon arastrmx_172977_21_pp_293-294.pdf
  • 3
293-294
  • Turkish

REFERENCES

References: 

1. An epidemiological approach to describing risk associated with
blood pressure level. Final report of the Working Group on Risk
and High Blood Pressure. Hypertension 1985; 7: 641-651
2. Kearns AE, Thompson GB: Medical and surgical management of
hyperparathyroidism. Mayo Clin Proc 2002; 77: 87-91
3. Mihai R, Farndon JR: Parathyroid disease and calcium metabolism.
Br J Anaesth 2000; 85: 29-43
4. Silverberg SJ, Shane E, Jacobs TP, Siris E, Bilezikian JP: A 10 year
prospective study of primary hyperparathyroidism with or without
parathyroid surgery. N Engl J Med 1999; 341: 1249-1255
5. Bilezikian JP, Brandi ML, Rubin M, Silverberg SJ: Primary
hyperparathyroidism: New concepts in clinical, densitometric and
biochemical features. J Intern Med 2005; 257: 6-17
6. Simonds WF, James-Newton LA, Agarwal SK, Yang B, Skarulis,
MC, Hendy GN, Marx SJ: Familial isolated hyperparathyroidism:
Clinical and genetic characteristics of thirty-six kindreds. Medicine
(Baltimore) 2002; 81: 1-26
7. Potts JT Jr: Diseases of the parathyroid gland and other hyper- and
hypocalcemic disorders. In: Harrison TR, Braunwald E. Harrison’s
Principles of internal medicine. 15th ed. New York: McGraw-Hill
2001:8-22
8. Bilezikian JP, Potts JT Jr, Fuleihan Gel-H, Kleerekoper M, Neer
R, Peacock M, Rastad J, Silverberg SJ, Udelsman R, Wells SA Jr:
Summary statement from a workshop on asymptomatic primary
hyperparathyroidism: A perspective for the 21st century. J Bone
Miner Res 2002; 17: 2-11
9. Silverberg SJ: Natural history of primary hyperparathyroidism.
Endocrinol Metab Clin North Am 2000; 29: 451-464
10. Sancho JJ, Rouco J, Riera-Vidal R, Sitges-Serra A: Long-term
effects of parathyroidectomy for primary hyperparathyroidism on
arterial hypertension. World J Surg1992; 16: 732-736

Thank you for copying data from http://www.arastirmax.com